United Therapeutics' (UTHR) Tyvaso DPI NDA Will get CRL From FDA (Revised)

United Therapeutics’ (UTHR) new drug utility for Tyvaso DPI to deal with PAH & PH-ILD fails to safe approval from the FDA. The inventory declines resultantly.

Source link